The current evidence suggests that GLP-1 RAs should be considered as part of a comprehensive obesity management strategy for adolescents who meet specific criteria, including failure of lifestyle interventions, presence of comorbidities, and adequate support systems
Conveniencia La forma inyectable se administra una vez a la semana, lo que puede resultar ms cmodo para algunas personas
Despite soaring use among celebrities and the public alike, not everyone who can benefit from anti-obesity medications has access to these novel drugs, according to a new study led by School of Public Health researchers
SURMOUNT 4 trial- Weight regain after stopping Tirzepatide (Mounjaro) after 36 weeks versus continuation of treatment Tirzepatide is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm
The studys systematic approachbuilding a detailed atlas of health outcomesprovides a framework for guiding clinical care and future research